Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model (Q36319704)

13 August 2017

Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model (English)

1 reference

13 August 2017

1 reference

1 reference

Alexander Kutikov

1

1 reference

13 August 2017

Brian L Egleston

2

1 reference

13 August 2017

Daniel Canter

3

1 reference

13 August 2017

Marc C Smaldone

4

1 reference

13 August 2017

Yu-Ning Wong

5

1 reference

13 August 2017

Robert G Uzzo

6

1 reference

13 August 2017

language of work or name

English

0 references

publication date

18 October 2012

1 reference

13 August 2017

1 reference

13 August 2017

188

1 reference

13 August 2017

6

1 reference

13 August 2017

2077-2083

1 reference

Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

Impact of comorbidity on survival among men with localized prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

30 September 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

30 September 2017

Overdiagnosis in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

Certain death in uncertain time: informing hope by quantifying a best case scenario

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

Development of a comorbidity index using physician claims data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

Cancer and comorbidity in older patients: a descriptive profile.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

Comorbidity and competing risks for mortality in men with prostate cancer.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

Uncertainty in assessing value of oncology treatments

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

Cancer rates, medical comorbidities, and treatment modalities in the oldest patients

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to".

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

A competing-risks nomogram for sarcoma-specific death following local recurrence

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4659779

A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma

5 December 2018

1 reference

12 December 2020

Rising incidence of small renal masses: a need to reassess treatment effect

1 reference

12 December 2020

Cure Me Even If It Kills Me: Preferences for Invasive Cancer Treatment

1 reference

12 December 2020

The assessment of patient life-expectancy: how accurate are urologists and oncologists?

1 reference

12 December 2020

Importance of comorbidity in competing risks analysis in patients with localized renal cell carcinoma

1 reference

12 December 2020

Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinoma

1 reference

12 December 2020

Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis

1 reference

12 December 2020

Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older

1 reference

12 December 2020

10.1016/J.JURO.2012.07.100

Identifiers

DOI

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

23083850

1 reference